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CLINICAL UPDATES
Virtual and in-person cardiac rehabilitation
Hasnain M Dalal, 1 , 2 Patrick Doherty, 3 Sinead TJ McDonagh, 2 Kevin Paul, 4 Rod S Taylor5
What you need to know
• Most eligible patients with coronary heart disease
and heart failure do not participate in cardiac
rehabilitation. Covid-19 has exacerbated this, with a
substantial drop in the number of patients
participating
• Home and telehealth based interventions are
increasingly being used as alternatives to traditional
centre based rehabilitation programmes
• Outcomes for patients participating in home based
rehabilitation compare favourably with centre based
programmes in terms of hospitalisations, quality of
life, and cost
• Telehealth based interventions are promising, but
some patients may find these interventions
challenging
• Novel ways of delivering rehabilitation have been
employed during the covid-19 pandemic, including
hybrid models that are likely to be offered as
alternatives to centre based rehabilitation in future,
enabling greater patient choice and greater uptake
of cardiac rehabilitation
Before the covid-19 pandemic, 100 000 people were
admitted to hospital with heart attacks and
approximately 200 000 were diagnosed with heart
failure annually in the UK.1 An estimated 7.4 million
people in the UK live with cardiovascular diseases,
and this is likely to increase with improved survival
following coronary heart disease and an ageing
population.1
A 2020 European position paper, in keeping with
other national and international guidelines,2 3 stated
that “comprehensive cardiac rehabilitationhas been
recognised as the most cost effective intervention to
ensure favourable outcomes across a wide spectrum
of cardiovascular disease.”4 Benefits include
improvements in morbidity, hospital admissions,
physical activity, exercise capacity, psychological
wellbeing, and health related quality of life.3 -11
Patient groups set to benefit are categorised, by
evidence level, in box 1. To achieve these benefits, it
is recommended that all core components of cardiac
rehabilitation (box 2) are included ina comprehensive
programme.4 Guidelines from the UK also advocate
long termstrategies to promote secondaryprevention
inprimary care and service evaluation throughaudit.3
Box 1: Patient groups who benefit from cardiac
rehabilitation4
High level evidence
• Post-acute coronary syndrome (ACS), post-primary
coronary angioplasty, and coronary artery surgery:
‐ o Patients with ACS (class 1, level A,12 13 including
ST-segment elevation myocardial infarction,
non-ST-segment elevation myocardial infarction,
and unstable angina (class 1, level B12)‐ oAll patients undergoing reperfusion (eg, coronary
arterybypassgraft, primarypercutaneous coronary
intervention, and percutaneous coronary
intervention (class 1, level A12)
• Chronic heart failure:‐ o Patients with newly diagnosed chronic heart
failure and chronic heart failurewith a step change
in clinical presentation (class 1, level A10 11)
Limited evidence
• Patients with heart transplant and ventricular assist
devices
• Post-valve heart surgery (open and percutaneous)
• Adults and adolescentswith congenital heart disease
• Atrial fibrillation
Unlike other international guidelines, evidence informing
guidance from the National Institute for Health and Care
Excellence is assessed based on Grading of
Recommendations, Assessment, Development, and
Evaluations (GRADE) criteria—the class/level approach
is not used and therefore not referenced above
Box 2: Core components of cardiac rehabilitation,
according to broad international consensus4
• Patient assessment‐ o Clinical history‐ o Symptoms‐ o Physical examination‐ o Investigations: electrocardiogram, cardiac
imaging, blood tests‐ o Physical activity level‐ o Peak exercise capacity—eg, bicycle ergometer,
treadmill, validated walk test
• Physical activity counselling‐ o Type and level‐ o Education‐ o Barriers to exercise‐ oExercise for patients unable to engage inwalking
or cycling based activities
• Exercise training‐ o Individualised prescribing‐ o Frequency, intensity, time (duration), and type
of exercise (FITT), or FITT related tomealtime (FITT
+T)
• Diet/nutritional counselling
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‐ o Assessment‐ o Education‐ o Healthy food choices
• Weight control management‐ o Assessment‐ o Education‐ o Weight reduction
• Lipid management‐ o Assessment‐ o Diet, physical activity, and medication
• Blood pressure management‐ o Assessment‐ o Lifestyle intervention and medication
• Smoking cessation‐ o Smoking status, including other tobacco products‐ o Encouragement to stop smoking all tobacco‐ o Referral for smoking cessation
• Psychosocial management‐ o Assessment of psychosocial risk factors‐ o Referral for behavioural and psychosocial intervention‐ o Vocational reintegration/return to work
• Evaluation of programme results‐ o Determination of success and failure of interventions‐ o New rehabilitative goals‐ o Communication regarding continuing care‐ o Quality assurance using systematic registration‐ o Structured follow-up
Even before the covid-19 pandemic, most patients in high and low
tomiddle incomecountrieswerenot offered cardiac rehabilitation514
and uptake was low. Lockdown measures owing to covid-19 have
exacerbated this problem.15 16 Provision and use of cardiovascular
healthcare have decreased worldwide, with substantial numbers
of patients in Europe and North America unable to access routine
hospital care.15 16 In theUK, covid-19 shielding guidance for patients
with cardiovascular disease and redeployment of NHS staff to acute
services have notably reduced access to and use of these services.17
This clinical update describes pre-pandemic evidence for cardiac
rehabilitation and considers how adoption of a broader range of
evidence based delivery methods can improve uptake and patient
outcomes during the pandemic and beyond.
Cardiac rehabilitation before the pandemic
Historically, rates of referral to cardiac rehabilitation were
suboptimal in the US18 19 and UK (<15% for heart failure).20 Uptake
was also poor, with only 68 074 (50%) of the 135 861 patients with
coronary heart disease in England, Wales, and Northern Ireland
accepting an offer of cardiac rehabilitation in the 12 months before
the pandemic.21
Most patients referred for rehabilitation after a cardiac event were
offered supervised, groupbased classes,which ranged in frequency,
intensity, duration of exercise, and self-help guidance.4 21 Cardiac
rehabilitation was usually delivered in hospital outpatient
departments or community centres, or (in some parts of Europe) as
inpatient services.4Collectively, thesemodes of delivery are termed
“centre based cardiac rehabilitation.”Despite compelling evidence
for clinical and cost effectiveness, participation in centre based
programmes remained suboptimal, with overall participation rates
<20% in the US22 and similar rates after a diagnosis of heart failure
in Europe.23 Poor participation predominated in certain groups:
women, older people, ethnic minorities, and those living in rural
communities or who are socioeconomically deprived.4 21 24
Consequently, calls were made for alternatives to centre based
cardiac rehabilitation.25 Suggested interventions included
rehabilitation at home facilitated by healthcare professionals and
supported by telehealth technologies, to improve uptake.26 An
American scientific statement in 2019advocatedhomebased cardiac
rehabilitation,9 and guidance from theNational Institute for Health
and Care Excellence (NICE) on chronic heart failure in the UK in
2018 stated that “delivery of homebased rehabilitationmay increase
access and uptake.27 Hybrid models involving a combination of
home and centre based rehabilitation have been evaluated28 but
not implementedwidely.9Tele-rehabilitation—“rehabilitation from
a distance by using one or several devices monitoring and
communicating patient specific information to the caregivers,”29
which often involves telephones, videoconferencing, and mobile
apps (telehealth)30—is increasingly used, often as an adjunct to
home based rehabilitation.
Box 3 summarises keynational and international recommendations
on cardiac rehabilitation. Box 4 discussesways to improve delivery
of cardiac rehabilitation for patients, including under-represented
populations.
Box 3: Key recent recommendations on cardiac rehabilitation
World Health Organization
• In 2017, WHO issued a statement committing to key actions to
strengthen cardiac rehabilitation services and highlighted the
evidence indicating the benefits of rehabilitation after acute
myocardial infarction.31 Rehabilitation should be “part of universal
health coverage and should be incorporated into the package of
essential services, along with prevention, promotion, treatment, and
palliation”31
UK
• The 2018 NICE guidance on chronic heart failure states that
rehabilitation “should be provided in a format and setting (at home,
in the community, or in the hospital) that is easily accessible for the
person”27
• The NHS Long Term Plan similarly underlines the importance of
rehabilitation and has set an ambitious target of 85% of eligible
patients being able to access care by 202832
• The importance of cardiac rehabilitation and delivering cardiac
rehabilitation during the covid-19 pandemic is discussed in a





• In response to the covid-19 outbreak, the American Association of
Cardiovascular and Pulmonary Rehabilitation has established the
InnovativeDeliveryModel Collaborative to facilitate digital approaches
and encourage home based delivery of rehabilitation. It offers
webinars on virtual cardiac and pulmonary rehabilitation.
https://www.aacvpr.org/Learn/Learning-Center/Virtual-Rehab-Mod-
ule-Series










































































































• A US scientific statement from 2019 noted that only a minority of
eligible patients participate in rehabilitation and recommendedhome
based interventions for low tomoderate risk patients unable to access
centre based programmes9
• In 2016, the Million Hearts Cardiac Rehabilitation Collaborative of
100 organisations developed a road map to increase participation in
rehabilitation from 20% to 70% by 202219 24
Europe
• A2020Europeanpositionpaper focuseson centre basedprogrammes
but does not comprehensively consider homebased interventions433
• A paper from the European Association of Preventive Cardiology on
recent cardiac tele-rehabilitation studies provides a practical guide
for the setupof rehabilitation services during the covid-19 pandemic16
Covid-19
• The emergence of covid-19 has prompted calls for accelerated
introduction of alternative methods of delivery that include home
based and tele-rehabilitation options15 16 30 34
Box 4: Improving delivery of care for patients, including
under-represented populations
Increasing referral to cardiac rehabilitation
• Referral to cardiac rehabilitation can be increased through automatic
referral at discharge,which canbe enhancedby informing thepatient
of the benefits of the intervention18 25 35 and by making referral a
“quality of care indicator”36
Addressing health inequalities
• Engagementwith cardiac rehabilitation is determined by service level
and patient level factors—for instance, age, sex, ethnicity, level of
deprivation, timing of rehabilitation, and mechanism of referral37‐ o Economic evaluations of data from the British Heart Foundation
National Audit of Cardiac Rehabilitation confirm uptake rates of
37.6% and 51.7% for the most and least deprived populations,
respectively37‐ o Patients who are given a firm date to attend their initial
rehabilitation assessment are more than four timesmore likely to
engage in rehabilitation programmes38
Covid-19 has exacerbated health inequalities, with poor outcomes in
marginalised populations, and has prompted calls to establish equitable
care models “that build culturally appropriate communication and
outreach practices to communicate with patients beyond traditional
phone calls and office visits”39
Lower rates of digital literacy and access have also been reported in other
marginalised groups during the pandemic.39 Differences in the digital
literacy of the healthcareworkforce also need to be considered.40 Further
research on implementation of telehealth and home based approaches
in cardiac rehabilitation is urgently needed to inform providers and
commissioners.29 41
Cardiac rehabilitation during the pandemic
The number of patients with heart failure in the UK participating
in rehabilitation decreased from 4969 (<10% of eligible patients)
before thepandemic (May 2019-January 2020) to 1474 (<5%of eligible
patients) during the first wave (February-August 2020).42 Analysis
by the British Heart Foundation (BHF) published in 2020 mirrored
other cardiac audits, showinga 30-40%decrease inuseof cardiology
and rehabilitation services because of the pandemic comparedwith
a similar period in 2019.17 43 Covid-19 has therefore led to further
calls for alternatives to traditional centre based cardiac
rehabilitation programmes, with an emphasis on home based and
digital technologies to provide virtual access.15 16
Indeed, although overall uptake of cardiac rehabilitation has
decreased, the proportion of patients receiving home based
rehabilitation in the UK has increased more than threefold since
the pandemic—from 22.2% to 72.4%42—as more services began to
offer home based and remote delivery.17 The rapid adoption of
technology in response to suspension of centre based rehabilitation
in the pandemicwas also reported in an international survey of 330
cardiac rehabilitation healthcare professionals.44 Use of
tele-rehabilitation can provide “a safe solution for patients, family,
and staff in themidst of covid-19.”30 Examples of how programmes
have adapted the delivery of rehabilitation in the pandemic have
been sharedbyNICE.4546Reportingby theBHFonmodes of delivery
in response to covid-19 now includes greater detail on 11 different
cardiac rehabilitation interventions, including nine types of home
based, virtual, and hybrid programmes.17
How can exercise capacity be assessed remotely during
the pandemic?
Baseline assessment of exercise capacity is core to the effective and
safe delivery of exercise interventions.3 In the UK, the incremental
shuttle walk test, step test, and six minute walk test are part of
routine practice3 and are monitored by local programmes and
reported nationally through the BHF audit. In response to covid-19,
most cardiac rehabilitationprogrammeshave adjusted assessments
to include greater use of submaximal step tests, two and three
minutewalk tests, andothermore subjective approaches, including
physical activity questionnaires (eg, theDukeActivity Status index),
fitness apps, andobservation of patients carrying out activities such
as chair based exercise or using hallways and stairs at home.
Several publications from North America and Europe discuss how
to adapt anduse different baseline fitness tests to assess the relative
risk of exercise.15 16 30 47 Risk assessment to determine whether
patients have a fitness level below five metabolic equivalents and
a proportional response (eg, heart rate and rating of exertion) to
exercise is a key focus15 47 48 (box 5). Such changes are envisaged
as temporary adjustments,47 as programmes had already started to
reintroduce fitness tests before the January 2021 lockdown in the
UK.However, robust studies of innovations—drivenby covid-19—in
home based assessment of exercise capacity could validate them
for the future portfolio of exercise tests.
Box5: Practical tips for remote/virtual delivery of cardiac rehabilitation15
• Make it easy‐ o Use tip sheets to help staff adjust to delivering care virtually‐ o Avoid becoming overwhelmed by the multitude of available
resources by finding a single, comprehensive, verified online
resource for patients and staff
• Don’t wait‐ o Encourage patients to attend at minimum intake assessments
to discuss the merits of virtual cardiac rehabilitation‐ o Follow a shared decisionmaking process for enrolment in virtual
rehabilitation, to ensure patients understand potential risks and
benefits of participating virtually versus choosing to delay care
• Focus on core components*‐ o Consider lifestyle risk management, psychosocial support,
medical advice, education‐ o Provide simple exercise prescriptions aimed at encouraging
low-to-moderate physical activity










































































































• Obtain patient metrics‐ o Examples include a self-administered six minute walk test for
exercise capacity, using patients’ personal scales and blood
pressure cuffs
• Offer group sessions‐ o Reduce “labour intensive” one-to-one sessions when possible
by providing group tele-/video-conferencing for educational
sessions and patient support
• Evaluate‐ o Formalise an evaluationprocess to assess themerits andefficacy
of virtual care
• Invest in access‐ o For rural and/or under-resourced areas, consider purchasing
tablets, smartphones, or other electronic options for loan to
participants to enhance a one-to-one personal experience
*Moulson et al suggest that it is possible to complete assessment of the
core components digitally/virtually, including an exercise test, albeit
with the limitations15
How do home and centre based cardiac rehabilitation
programmes compare?
The UK, Australia, and Canada have been key adopters of home
based cardiac rehabilitation.9 In the UK, the Heart
Manual—acknowledged as the “most extensively studied
self-managementprogramme”9—hasbeenusedby theNHS formore
than 10 years. Box 6 lists advantages and disadvantages of home
based cardiac rehabilitation.
Box 6: Advantages and disadvantages of home based versus centre
based cardiac rehabilitation9
Potential advantages
• Reduced enrolment delays
• Expanded capacity/access
• Individually tailored programmes
• Flexible, convenient scheduling
• Minimal travel/transportation barriers
• Greater privacy while receiving cardiac rehabilitation
• Integration with regular home routine
Potential disadvantages
• Lack of reimbursement*
• Less intensive exercise training
• Less social support
• Less patient accountability
• Lack of published standards for home based cardiac rehabilitation
• Less face-to-face monitoring
• Safety concerns for high risk patients
*Lack of reimbursement is an issue in some countries; however, the
Centers for Medicare and Medicaid Services in the US introduced
reimbursements for virtual cardiac rehabilitation in 202049
The standards and core components (box 2) used in many home
based cardiac rehabilitation studies are comparable with those in
studies of centre based interventions).9 Cochrane reviews in
coronary heart disease and heart failure consistently report
statistically significant reductions inhospital admissionswith centre
and home based cardiac rehabilitation compared with usual care.5
In an updated Cochrane review that included 44 randomised
controlled trials (10 home based and 34 centre based), the relative
risk reduction for all causehospitalisationwas0.70 (95%confidence
interval (CI) 0.60 to 0.83)). Studies that directly or indirectly
compared home and centre based cardiac rehabilitation found no
statistically significant difference in 12 month mortality between
the two approaches.6 -9 A systematic review of 31 randomised
controlled trials reported that home based and hybrid cardiac
rehabilitation models can improve exercise capacity and are
potential alternatives to centre based programmes.50
A meta-analysis of individual participant data and the updated
Cochrane review showed that participation in homeor centre based
cardiac rehabilitation after heart failure resulted in a clinically
meaningful improvement inhealth relatedquality of life, determined
using the Minnesota Living with Heart Failure questionnaire score
(7.1 (95% CI -3.7 to -10.5)), compared with no rehabilitation.6 51
Improvements in health related quality of life were reported for 11
of 13 trials of home versus centre based cardiac rehabilitation using
various validated questionnaires, with no statistically significant
difference between the two groups.9
Improvements inmodifiable cardiovascular risk factorswith cardiac
rehabilitation are documented in a US scientific statement.9
Differential effects on weight, blood pressure, lipids, and tobacco
use were similar in the eight home versus centre based cardiac
rehabilitation trials that were included (fig 1).9










































































































Fig 1 | Structure, process, and outcome metrics for home based cardiac rehabilitation. Reproduced with permission9
Adherence to homebased cardiac rehabilitation is comparablewith
that in centre based programmes; however, considerable variation
is seen in reporting of adherence, and the US scientific statement
noted limited ability to pool data to compare homeand centre based
programmes.9 No statistically significant difference in adherence
was reported between the two settings in a Cochrane review that
included seven studies; however, three of the studies showedbetter
adherence to home than centre based cardiac rehabilitation (RR
1.04 (95%CI 1.01 to 1.05); P=0.009).7Asmall qualitative studynested
within a randomised controlled trial reported that most patients,
given the choice, prefer home based cardiac rehabilitation (57%
versus 43%).52 Indeed, European and NICE guidelines recommend
home based rehabilitation with or without telemonitoring, as
evidence suggests that home based programmes can increase
participation and support behaviour change.2 27A large prospective
cohort study of 151 centres with 99 097 patients in the US reported
that patients referred to home based cardiac rehabilitation were
four timesmore likely to participate than those offered centre based
programmes.9 53 In response to covid-19, the Centers for Medicare
and Medicaid Services in the US introduced reimbursements for
virtual andhomebased cardiac rehabilitation fromOctober 2020.49
ACochrane review concluded that clinical benefits with centre and
home based cardiac rehabilitation in patients with heart failure,
myocardial infarction, and coronary revascularisation are similar
andwith equivalent costs.7 In this and theupdatedCochrane review
of rehabilitation for adultswith heart failure, gains in health related
quality of life and costs between home and centre based
rehabilitation were also comparable.6 7Box 7 summarises the
evidence for the cost effectiveness of home based programmes.
Box 7: Cost effectiveness of home based cardiac rehabilitation and
tele-rehabilitation
• A systematic review that examined economic evaluations in cardiac
rehabilitation published since 2001 concluded that cardiac
rehabilitation was cost effective compared with usual care54‐ o Incremental cost effectiveness ratios (ICERs) ranged from$1065
to $71 755 (£751 to £50648;€869 to€58 557) per quality adjusted
life year (QALY), although no significant differences in costs and
QALYs were reported in two studies that directly compared home
and centre based rehabilitation54
‐ o Tele-rehabilitation was used in four included studies and was
considered to be cost effective in all, but with wide ranging ICERs
(from dominant (cardiac rehabilitation less costly and more
effective than usual care) to $588 734 per QALY)54‐ o The authors called for larger studies to strengthen the evidence
base, observing a potential reduction in costs if tele-rehabilitation
were more widely adopted and noting that patient adherence to
digital technologies is variable54
• Health economic modelling based on a recent multicentre trial in
patients with heart failure concluded that home based cardiac
rehabilitation can be cost effective in the health service setting in the
UK55
• A facilitatedhomebased cardiac rehabilitation intervention for people
withheart failure and their caregivers: a researchprogramme including
the REACH-HF RCT56
How do tele-rehabilitation and centre based cardiac
rehabilitation programmes compare?
Tele-rehabilitation interventions are promising and are replacing
centre basedprogrammes as part of homebased approaches during
the pandemic.30 In a trial of 162 adults with coronary heart disease,
which compared the effects of remotely monitored rehabilitation
(by smartphone and web apps) with centre based programmes,
remote cardiac rehabilitation was “an effective, cost efficient
alternative delivery model that could improve overall utilisation
rates by increasing reach and satisfying unique participant
preferences.”57 However, caution is urged when implementing
telehealth based interventions, as the mean age in most studies is
less than 60 years. Some patients may find such interventions
challenging without facilitated support.4 29 41 Ensuring quality
assurancewith telehealthbasedmodes of delivery is alsopotentially
challenging.9 16 29
A systematic review and meta-analysis that included 30 telehealth
trials of secondary prevention in patients with coronary heart
disease reported statistically significant lower re-hospitalisation
and cardiac events (RR 0.56 (95% CI 0.39 to 0.81), P<0.0001) in the
intervention groups. The authors concluded that telehealth










































































































interventions could be offered to patients unable to attend centre
based rehabilitation.58
Anothermeta-analysis, which reviewed 11 trials (n=1189), reported
that telehealth interventions were at least as effective as centre
based programmes for improving modifiable cardiovascular risk
factors and exercise capacity.59 Adherence to exercise was
significantly higherwith telehealth (fixed effect standardisedmean
difference 0.75 (95% CI 0.52 to 0.98)).59 Telehealth rehabilitation
programmes can also quantify adherence to home based
programmes throughwearable accelerometer devices linked to the
internet.9
Conclusion
Poor rates of participation in conventional cardiac rehabilitation
programmes led to the development of home based and digitally
delivered interventions,which are supportedby emerging evidence.
Covid-19 has provided an opportunity “to reimagine how cardiac
rehabilitation is delivered.”49 In the future, patients with
cardiovascular disease are likely to be offered alternatives to centre
based cardiac rehabilitation, including hybrid models, which will
provide patient choice52 and should increase overall uptake in
keeping with ambitious national targets in the US and UK.19 32
Education into practice
• How well do you know the local pathways to refer patients for home
based cardiac rehabilitation after a heart attack or new diagnosis of
heart failure?
• In patientswith a newdiagnosis of heart failure, howmanyhavebeen
referred to and participated in a cardiac rehabilitation programme in
the past 12 months?
Ongoing research and unanswered questions
Ongoing research
• The National Institutes for Health Research (NIHR) Health Technology
Assessment (HTA) Programme is funding a study based in the UK: A
randomised controlled trial of a facilitated homebased rehabilitation
intervention in patients with heart failure with preserved ejection
fraction and their caregivers: the REACH-HFpEF Study (2021-2024)60
• The Western Norway Health Authority has funded a study of 3000
patients offered cardiac rehabilitation after a percutaneous coronary
intervention,61whichwill allow comparison of outcomeswith another
study on hospitalisation of older adults after acute myocardial
infarction62: Rethinking rehabilitation after percutaneous coronary
intervention: a multicentre cohort study on continuity of care, health
literacy, adherence, and costs at all care levels (the CONCARDPCI)
study61
• The Improving ATTENDance in Cardiac Rehabilitation Trial (iATTEND)
(2019-23)63: A randomised trial of 270 patients in the US to assess
the efficacy of a hybrid approach to delivery of cardiac rehabilitation
on attendance by combining both centre based and remote or home
based cardiac rehabilitation sessions. The intervention group
combines centrebasedand remote/homebasedcardiac rehabilitation
and is tailored to the individual needs of each patient, accomplished
with the assistance of an easy-to-access telecommunicationsmethod
(telemedicine)
Unanswered questions4 9 64
• What is the impact of‐ o home based services in more diverse and higher risk groups of
patients?‐ o hybrid models of cardiac rehabilitation, including components
from both centre and home based settings?
• What are the barriers for using digital health technologies including
wearable monitoring devices for cardiac rehabilitation in terms of
factors that are‐ o patient related?‐ o clinician related?‐ o legal and ethical issues?‐ o interoperability and technical issues?‐ o lack of reimbursement?
• What studydesigns shouldbeused to evaluatemultimorbidity cardiac
rehabilitation programmes?
• What is the feasibility of delivering cardiac rehabilitation through
primary care networks?
• Can we improve inequality in the uptake of cardiac rehabilitation by
culturally adapting programmes for ethnic minority groups?
How patients were involved in the creation of this article
Cindy Edgeler is married to Chris, a retired roadman with Cornwall
Highways, whowas admitted to hospital with a heart attack in 2012 (Box
“A carer’s story by Cindy Edgeler”). Chris was a patient of coauthor HD,
and both Cindy and Chris were members of the Patient and Public
Involvement Group that was part of the Rehabilitation Enablement in
CHronic Heart Failure (REACH-HF) National Institute for Health Research
(NIHR; RP-DG-0709-10111) funded clinical trial. Cindy and Chris reviewed
a draft version of the clinical review.
We also received feedback from patients supported by the Wirral
Community Cardiology Service,whohavebeendelivering REACH-HF since
2019 and throughout the COVID-19 outbreak.
https://www.nice.org.uk/sharedlearning/delivering-rehabilitation-en-
ablement-in-chronic-heart-failure-reach-hf-in-wirral
Our patient coauthor KP has been amember of the REACH-HF study group
for several years, having had a heart attack in 2008. KP reviewed and
provided input to this manuscript and talks about his experience of
receiving CR in a podcast from our 2015 BMJ clinical review, which is
available at: https://soundcloud.com/bmjpodcasts/cardiac-rehab-pa-
tient.
Our patient advisers acknowledged theusefulness of thedigital approach
to cardiac rehabilitation, especially for thosewho struggle to get to centre
based sessions. But they also highlighted the need for a more hybrid
approach so that rehabilitation is as accessible as possible. The final
manuscript was modified to reflect the patients’ views.
A carer’s story, by Cindy Edgeler
My husband had a heart attack in 2012, which also left him with heart
failure. After having stents fitted on the day he was admitted to hospital,
he was well looked after on the critical care ward, and then came home.
Although he received good aftercare, I felt that I had no support and was
left tomy own devices. I hadmany questions, worries, and fears. I would
lie next to him at night while he slept and wonder if each breath would
be his last. He would say: “Stop asking me if I'm alright.”
There was no one I felt I could talk to, and I needed reassurance.
A few months later, we were offered the Rehabilitation Enablement in
CHronic Heart Failure (REACH-HF) home based cardiac rehabilitation
programmeandwere presentedwith theHeart FailureManual and Family
& Friends Resource for Carers, which importantly linked me to a nurse
facilitator. From the first meeting there was a stark contrast with our
previous experience, in that it was not just about the care ofmy husband
but also about my own wellbeing. The facilitator answered all of my
questions, and I knew I had a point of call should anything giveme cause
for concern.
I recall that I was concerned about my husband’s breathlessness on one
home visit, and the nurse facilitator explained by giving me an analogy
of: “You wouldn’t expect your car to pull away in fourth gear, you start in










































































































first and move slowly through the gears.” This made complete sense to
me then.
My husband has other comorbidities that affect his walking and general
fitness, and this is why the home based exercises are somuch better for
our situation. We do the chair based exercise DVD together; we are able
to pace ourselves and decide which level we start at. We continue with
weekly weigh-ins to ensure we keep within healthy limits, and we found
the progress tracker helped to monitor progress.
Thepatientmanual itself was a tool thatweused—and still use—together.
There is a separatemanual/resource just for caregivers, which I find very
useful.
A video featuring Cindy and Chris Edgeler can be viewed at http://theb-
mjawards.bmj.com/showcase/.
Additional educational resources for patients and carers
• American Heart Association: what is cardiac rehabilitation?
www.heart.org/en/health-topics/cardiac-rehab/what-is-cardiac-reha-
bilitation
• Additional information on home based cardiac rehabilitation.
www.heart.org/en/news/2019/05/13/experts-urge-expansion-of-
home-based-cardiac-rehabilitation
• A telehealth cardiac rehabilitation programme for patients using a
free app to use on a mobile phone/device. www.henryford.com/ser-
vices/cardiology/support/cardiac-rehab/home-based-cardiac-reha-
bilitation
• British Heart Foundation: online exercise videos.
www.bhf.org.uk/informationsupport/heart-matters-magazine/activi-
ty/10-minute-workout
• Online patient education sessions available in six languages.
www.healtheuniversity.ca/en/CardiacCollege
• A choice of a book or digital format of a home based programme for
patients recovering from a heart attack or revascularisation.
https://services.nhslothian.scot/TheHeartManual/Pages/default.aspx
• A webinar on virtual rehabilitation and self-management techniques
during covid-19 for people living with heart conditions.
www.heartandstroke.ca/what-we-do/webinars/cardiac-rehab-during-
covid-19
All resources are open access with no registration, except the digital
format of the Heart Manual, which requires registration
How this article was created
We focusedonnewevidenceonhomebasedand telehealthbasedcardiac
rehabilitation that would be of interest to patients, clinicians, and
commissioners based on recent publications on the impact of covid-19
and our 2015 clinical review that was co-authored by HD, RST, and PD.
RST is a contributor and editor for the Cochrane Heart Group and has led
and conducted several systematic reviewsof cardiac rehabilitation. These
Cochrane reviews have been cited in various national guidelines, which
we consulted when writing this article. We referred to annual reports of
the National Audit of Cardiac Rehabilitation, which is led by PD, and the
BHF website for statistics on coronary heart disease in the UK. We also
consulted recent national statements and standards from the UK, US,
and Europe, and HD used his personal archive of references.
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